Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex
Wednesday, May 2, 2012 - 00:10
in Mathematics & Economics
Pfizer said in a regulatory filing with the Securities and Exchange Commission that it was taking a $450 million charge against first-quarter earnings to settle the case.